Combined with our experimental results, we hypothesized that TUSC2 repressed the malignant phenotypes of CRC cells, possibly by the induction of cell cycle arrest and apoptotic proteins and the inhibition of proliferation-related kinases, but further elucidation of this hypothesis is necessary to fully comprehend the underlying mechanisms. The gene discussed is PLK3; the disease is colorectal carcinoma.